1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > China Hospital Industry Report,2016-2020

China Hospital Industry Report,2016-2020

  • January 2017
  • -
  • Research In China
  • -
  • 141 pages

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging have prompted the rapid development of China's hospital industry. As of October 2016, there had been a total of 28,584 hospitals in China, an increase of 7,666 compared with that in 2010. It is estimated that Chinese hospitals gained the revenue of RMB2,708 billion in 2016, soaring 163.3% over 2010.

Chinese medical insurance system has been gradually perfect and medical resources have swelled radically, laying the foundation for the healthy and orderly development of the hospital industry. As of the end of 2015, a total of 666 million Chinese people had enjoyed urban basic medical insurance and 670 million people had held new rural cooperative medical insurance, marking the full coverage of medical insurance. At the same time, the national medical and health institutions had offered 7.015 million beds, namely 5.11 beds for per thousand population. According to Circular on Accelerating the Construction of Health and Old-age Service Project, medical and health institutions should provide 6 beds for per thousand population (including inpatients) averagely by 2020.

Driven by the reform of public hospitals and other policies, China has set off a wave of social capital inrush to the medical industry and witnessed an upsurge in the number of private hospitals. By the end of October 2016, there had been 15,798 private hospitals in China, accounting for 55.3% of the total hospitals. However, the revenue of private hospitals is less than 10% of the total hospital revenue. In the forthcoming years, Chinese private hospitals will grow by leaps and bounds, with the number registering 20,262 and the revenue reporting RMB639.6 billion by 2020.

Specialized hospitals need low investment costs but trigger high return on investment; coupled with the robust demand, they have attracted the fanatical investment of social capital. Private hospitals occupy more than 65% of Chinese specialized hospitals. In recent years, the revenue of Chinese specialized hospitals has been growing at around 20%; the current revenue exceeds RMB300 billion.

Among specialized hospitals, ophthalmic hospitals, stomatological hospitals as well as orthopedics & beauty hospitals enjoy exceedingly high profitability, with the profit margin of above 10%. For instance, Aier Eye Hospital, the nation's largest chain ophthalmic institution – boasts over 100 stores in the country and serves more than 3 million outpatients annually; in the first half of 2016, the company achieved the revenue of RMB1.92 billion, the net income of RMB280 million and the net profit margin of 14.6%.

The report highlights the following:
Overview of China hospital industry, including number of hospitals, revenue, medical services, competition pattern, forecast and prospect, etc.;
Status quo of specialized hospitals in China, including overview, analysis on specialized hospitals of all sorts, summary and forecast;
Overview of Chinese medical insurance system, embracing status quo and development trend;
Investment in China hospital industry, including related policies, comparison between public and private hospitals, investment of social capital, development directions and business models of foreign-funded hospitals;
Operation, hospital industry layout, development forecast, etc. of 15 enterprises.

Table Of Contents

China Hospital Industry Report,2016-2020
1. Overview of China Hospital Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of China Hospital Industry
2.1 Overview
2.1.1 Number of Hospitals
2.1.2 Distribution
2.2 Revenue
2.3 Medical Services
2.3.1 Patient Visits
2.3.2 Bed Utilization
2.4 Competition Pattern
2.5 Forecast and Prospect
2.5.1 Number and Revenue of Hospitals Will Grow Steadily
2.5.2 Public-private Partnership of Hospitals Becomes a General Trend
2.5.3 Number and Revenue of Private Hospitals Will See Steady Growth
2.5.4 Private Hospitals Tend to Be Professional
2.5.5 Private Hospitals Will Forge Brands Gradually

3. Development of Specialized Hospitals in China
3.1 Overview
3.1.1 Number of Specialized Hospitals
3.1.2 Revenue
3.2 Status Quo of Specialized Hospitals of All Kinds
3.2.1 Ophthalmic Hospital
3.2.2 Stomatological Hospital
3.2.3 Orthopedics and Beauty Hospital
3.2.4 Obstetrics and Gynecology Hospital
3.2.5 Children's Hospital
3.2.6 Tumor Hospital
3.3 Summary and Forecast

4 Development of Chinese Medical Insurance System
4.1 Status Quo
4.1.1 Medical Insurance System
4.1.2 Coverage of Medical Insurance System Is Close to Saturation
4.1.3 Serious Illness Insurance for Urban and Rural Residents
4.2 Development Trends
4.2.1 Urbanization Will Optimize Health Care System
4.2.2 Trans-regional Medical Insurance Settlement Will Be Promoted
4.2.3 Accumulated Balance of Medical Insurance Funds Grows Year by Year
4.2.4 Medical Resource Supply Capacity of County-level Hospitals Will Improve
4.2.5 Medical Resources Will Grow Rapidly

5. Investment in China Hospital Industry
5.1 Policies
5.2 Comparison between Public and Private Hospitals
5.2.1 Public Hospitals Play a Leading Role
5.2.2 Private Hospitals Run with High Efficiency
5.3 Investment Fields of Social Capital
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals
5.4 Development Orientation and Business Model of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China
5.4.2 Development Direction
5.4.3 Business Practice

6. Major Enterprises
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 RandD and Investment
6.1.6 Medical Services
6.1.7 Prediction
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Medical Services
6.2.6 Prediction
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 RandD
6.3.6 Medical Services
6.3.7 Prediction and Outlook
6.4 Shanghai Fosun Pharmaceutical (Group)
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 RandD and Investment
6.4.6 Medical Services
6.4.7 Prediction and Outlook
6.5 Jinling Pharmaceutical Company Limited
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 RandD and Investment
6.5.6 Medical Services
6.5.7 Prediction and Outlook
6.6 Shinva Medical Instrument
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 RandD and Investment
6.6.6 Medical Services
6.6.7 Prediction and Outlook
6.7 Xi'an International Medical Investment Co., Ltd.
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Medical Services
6.7.5 Prediction and Outlook
6.8 Inner Mongolia Furui Medical Science
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Medical Services
6.8.5 Prediction and Outlook
6.9 Wuhan Jianmin Pharmaceutical Groups Corp.
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Medical Services
6.9.5 Prediction and Outlook
6.10 Concord Medical Services Holdings Limited
6.10.1 Profile
6.10.2 Operation
6.10.3 Medical Services
6.10.4 Prediction and Outlook
6.11 Phoenix Healthcare Group
6.11.1 Profile
6.11.2 Operation
6.11.3 Medical Services
6.11.4 Prediction and Outlook
6.12 Guizhou Yibai Pharmaceutical
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Services
6.12.4 Prediction and Outlook
6.13 Kangmei Pharmaceutical
6.13.1 Profile
6.13.2 Operation
6.13.3 Medical Services
6.13.4 Prediction and Outlook
6.14 Jiangnan Mould and Plastic Technology
6.14.1 Profile
6.14.2 Operation
6.14.3 Medical Services
6.14.4 Prediction and Outlook
6.15 Beijing Meizhong Jiahe Hospital Management
6.15.1 Profile
6.15.2 Operation
6.15.3 Major Clients
6.15.4 Medical Services
6.15.5 Prediction and Outlook

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of ...

MediPoint: Operating Room Equipment - Global Analysis and Market Forecasts

MediPoint: Operating Room Equipment - Global Analysis and Market Forecasts

  • $ 5995
  • Industry report
  • November 2016
  • by GlobalData

MediPoint: Operating Room Equipment - Global Analysis and Market Forecasts Summary The ubiquity of operating tables, surgical lights, and supply units in operating rooms throughout the world has led to ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.